Figure 2

Changes in and Comparison of serum chemokine levels of DM-IP initially and at 2 weeks after treatment between survivors and non-survivors. (A) The time series of each chemokine; (B) The comparison of serum chemokine levels initially and at 2 weeks after treatment between the survival group and the death group; CCL: C-C motif chemokine ligand; CXCL: C-X-C motif chemokine ligand; closed square: alive patients (Alive); open square: patients dead due to interstitial pneumonia (Dead). The P value was estimated by Wilcoxon’s rank sum test. *P < 0.05.